Touyun Biotech Group Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Touyun Biotech Group.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Packaging earnings growth | 22.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%
Apr 22
Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?
Apr 08What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You
Feb 07Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding
Dec 18Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt
Sep 19Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)
Jul 28Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Sep 13Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt
May 18Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Dec 24Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?
Mar 12If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns
Jan 15
The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares
Jan 15How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?
Dec 11In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Touyun Biotech Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 199 | -269 | N/A | N/A | N/A |
| 9/30/2023 | 226 | -231 | N/A | N/A | N/A |
| 6/30/2023 | 253 | -194 | 37 | 49 | N/A |
| 3/31/2023 | 284 | -196 | -1 | 11 | N/A |
| 12/31/2022 | 316 | -198 | -39 | -26 | N/A |
| 9/30/2022 | 314 | -149 | -40 | 5 | N/A |
| 6/30/2022 | 313 | -100 | -40 | 36 | N/A |
| 3/31/2022 | 298 | -86 | -129 | -9 | N/A |
| 12/31/2021 | 284 | -73 | -217 | -54 | N/A |
| 9/30/2021 | 268 | -110 | -307 | -128 | N/A |
| 6/30/2021 | 252 | -148 | -398 | -203 | N/A |
| 3/31/2021 | 229 | -158 | -269 | -109 | N/A |
| 12/31/2020 | 207 | -169 | -141 | -15 | N/A |
| 9/30/2020 | 230 | -190 | -125 | -51 | N/A |
| 6/30/2020 | 252 | -212 | -109 | -87 | N/A |
| 3/31/2020 | 298 | -206 | -161 | -146 | N/A |
| 12/31/2019 | 343 | -201 | -213 | -205 | N/A |
| 9/30/2019 | 357 | -221 | -165 | -164 | N/A |
| 6/30/2019 | 371 | -242 | -117 | -122 | N/A |
| 3/31/2019 | 360 | -248 | -135 | -120 | N/A |
| 12/31/2018 | 349 | -254 | -153 | -117 | N/A |
| 9/30/2018 | 364 | -245 | -161 | -94 | N/A |
| 6/30/2018 | 378 | -236 | -168 | -71 | N/A |
| 3/31/2018 | 348 | -240 | -130 | -56 | N/A |
| 12/31/2017 | 318 | -245 | -93 | -41 | N/A |
| 6/30/2017 | 163 | -917 | N/A | -126 | N/A |
| 3/31/2017 | 62 | -1,006 | N/A | 50 | N/A |
| 12/31/2016 | -38 | -1,095 | N/A | 226 | N/A |
| 6/30/2016 | 58 | -357 | N/A | -300 | N/A |
| 3/31/2016 | 172 | -51 | N/A | -380 | N/A |
| 12/31/2015 | 286 | 255 | N/A | -459 | N/A |
| 9/30/2015 | 309 | 302 | N/A | N/A | N/A |
| 6/30/2015 | 332 | 349 | N/A | 173 | N/A |
| 3/31/2015 | 365 | 180 | N/A | 101 | N/A |
| 12/31/2014 | 397 | 10 | N/A | 28 | N/A |
| 9/30/2014 | 405 | 10 | N/A | 15 | N/A |
| 6/30/2014 | 414 | 10 | N/A | 2 | N/A |
| 3/31/2014 | 425 | 11 | N/A | 8 | N/A |
| 12/31/2013 | 436 | 13 | N/A | 14 | N/A |
| 9/30/2013 | 436 | 14 | N/A | 11 | N/A |
| 6/30/2013 | 435 | 15 | N/A | 9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1332's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if 1332's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1332's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1332's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1332's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1332's Return on Equity is forecast to be high in 3 years time